|

Internet-based Treatment of Stress and Anxiety in Myocardial Infarction With Non-obstructive Coronary Arteries

RECRUITINGN/ASponsored by Per Tornvall
Actively Recruiting
PhaseN/A
SponsorPer Tornvall
Started2021-11-11
Est. completion2024-11-30
Eligibility
Age35 Years – 79 Years
Healthy vol.Accepted

Summary

Patient with myocardial infarction with non-obstructive coronary arteries and takotsubo syndrome often have high levels of stress and anxiety. At present there are no treatment alternatives in this group of patients. Previously, cognitive behavioral therapy (CBT), primarily aiming at relieving stress, has been shown to decrease morbidity in patient with myocardial infarction with obstructive coronary arteries. The present open randomized study aims to decrease stress and anxiety in patients with myocardial infarction with non-obstructive coronary arteries and takotsubo syndrome by an internet-based CBT focusing on stress and anxiety.

Eligibility

Age: 35 Years – 79 YearsHealthy volunteers accepted
Inclusion Criteria:

* a suspected diagnosis of MINOCA or takotsubo syndrome with coronary angiography without diameter stenosis ≥50%
* age 35-80 years
* admission-ECG with sinus rhythm
* PSS-14 ≥ 25 and/or HADS-A ≥ 8 during admission
* reading and writing proficiency in Swedish
* computer/Internet access and literacy

Exclusion Criteria:

* strong clinical suspicion of myocarditis
* spontaneous coronary artery dissection
* acute pulmonary embolism
* acute myocardial infarction type 2
* cardiomyopathy other than takotsubo syndrome
* a previous myocardial infarction due to CAD
* expected poor compliance to behavioural therapy
* not likely to survive \> one year due to for example cancer

Conditions3

AnxietyHeart DiseaseMyocardial Infarction

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.